The Scientist

» drug discovery, immunology and evolution

Most Recent

From fish harvests to cottonwood forests, organisms display evidence that species change can occur on timescales that can influence ecological processes.

5 Comments

Guppies transplanted between different communities in Trinidadian streams evolved in response to changes in predation threat in just a few generations.

1 Comment

By analyzing the genomes of 161 dog breeds, scientists discover how and when certain canine breeds emerged.

1 Comment

The state’s board of education approves new standards that ease up on having students dig into scientific issues relevant to “intelligent design” arguments.

1 Comment

image: RNAi’s Future in Drug-Target Screening

RNAi’s Future in Drug-Target Screening

By | April 17, 2017

A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

0 Comments

image: Viral Trigger for Celiac Disease?

Viral Trigger for Celiac Disease?

By | April 6, 2017

A common, seemingly benign human virus can trigger an immune response that leads to celiac disease in a mouse model, researchers show. 

3 Comments

image: New Giant Virus Group Reported

New Giant Virus Group Reported

By | April 6, 2017

A genomic analysis of “Klosneuviruses” suggests that they evolved from small viruses that accumulated genetic material over time, but not all virologists are convinced. 

0 Comments

image: Gel Scaffolds for Delivery of Immunotherapies

Gel Scaffolds for Delivery of Immunotherapies

By | April 1, 2017

Using biocompatible polymers to carry cancer immune therapies directly to the tumor

0 Comments

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

0 Comments

image: Neoantigens Enable Personalized Cancer Immunotherapy

Neoantigens Enable Personalized Cancer Immunotherapy

By | April 1, 2017

Tumors’ mutations can encode the seeds of their own destruction, in the form of immunogenic peptides recognized by T cells.

1 Comment

Popular Now

  1. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  2. Can Young Stem Cells Make Older People Stronger?
  3. Two Dozen House Republicans Do an About-Face on Tuition Tax
  4. Insects’ Neural Learning and Memory Center Discovered in Crustaceans